Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 826

2.

Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.

Takahashi N, Fujibayashi T, Kida D, Hirano Y, Kato T, Kato D, Saito K, Kaneko A, Yabe Y, Takagi H, Oguchi T, Miyake H, Watanabe T, Hayashi M, Kanayama Y, Funahashi K, Hanabayashi M, Hirabara S, Asai S, Takemoto T, Terabe K, Asai N, Yoshioka Y, Ishiguro N, Kojima T.

Rheumatol Int. 2015 May 20. [Epub ahead of print]

PMID:
25991396
3.

Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.

Müller RB, Kempis JV, Haile SR, Schiff MH.

Semin Arthritis Rheum. 2015 Mar 3. pii: S0049-0172(15)00044-X. doi: 10.1016/j.semarthrit.2015.02.009. [Epub ahead of print]

PMID:
25895697
4.

A Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate.

Pavelka K, Chon Y, Newmark R, Lin SL, Baumgartner S, Erondu N.

J Rheumatol. 2015 Apr 15. pii: jrheum.141271. [Epub ahead of print]

PMID:
25877498
5.

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study.

Smolen JS, Weinblatt ME, van der Heijde D, Rigby WF, van Vollenhoven R, Bingham CO 3rd, Veenhuizen M, Gill A, Zhao F, Komocsar WJ, Berclaz PY, Ortmann R, Lee C.

Ann Rheum Dis. 2015 Apr 14. pii: annrheumdis-2014-207090. doi: 10.1136/annrheumdis-2014-207090. [Epub ahead of print]

PMID:
25873635
6.

Longterm efficacy and safety of abatacept in patients with rheumatoid arthritis treated in routine clinical practice: effect of concomitant methotrexate after 24 weeks.

Takahashi N, Kojima T, Kaneko A, Kida D, Hirano Y, Fujibayashi T, Yabe Y, Takagi H, Oguchi T, Miyake H, Kato T, Watanabe T, Hayashi M, Kanayama Y, Funahashi K, Asai S, Yoshioka Y, Takemoto T, Terabe K, Asai N, Ishiguro N.

J Rheumatol. 2015 May;42(5):786-93. doi: 10.3899/jrheum.141288. Epub 2015 Apr 1.

PMID:
25834204
7.

Comparative effectiveness of tocilizumab with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.

Narváez J, Díaz-Torné C, Magallares B, Hernández MV, Reina D, Corominas H, Sanmartí R, de la Serna AR, Llobet JM, Nolla JM.

PLoS One. 2015 Apr 1;10(4):e0123392. doi: 10.1371/journal.pone.0123392. eCollection 2015.

8.

Early therapeutic intervention with methotrexate prevents the development of rheumatoid arthritis in patients with recent-onset undifferentiated arthritis: A prospective cohort study.

Kudo-Tanaka E, Shimizu T, Nii T, Teshigawara S, Yoshimura M, Watanabe A, Tsuji S, Tsuboi H, Hirao M, Yura A, Harada Y, Sueishi M, Suenaga Y, Chiba N, Tonai T, Saisho K, Ogata A, Matsushita M, Hashimoto J, Ohshima S, Tohma S, Saeki Y.

Mod Rheumatol. 2015 Apr 30:1-6. [Epub ahead of print]

PMID:
25800638
9.

Iguratimod for the treatment of rheumatoid arthritis in Japan.

Tanaka K, Yamaguchi T, Hara M.

Expert Rev Clin Immunol. 2015 May;11(5):565-73. doi: 10.1586/1744666X.2015.1027151. Epub 2015 Mar 22.

PMID:
25797025
10.

Apremilast in patients with active rheumatoid arthritis: A phase II, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Genovese MC, Jarosova K, Cieślak D, Alper J, Kivitz A, Hough DR, Maes P, Pineda L, Chen M, Zaidi F.

Arthritis Rheumatol. 2015 Mar 16. doi: 10.1002/art.39120. [Epub ahead of print]

PMID:
25779750
11.

Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry.

Fujibayashi T, Takahashi N, Kida D, Kaneko A, Hirano Y, Fukaya N, Yabe Y, Oguchi T, Tsuboi S, Miyake H, Takemoto T, Kawasaki M, Ishiguro N, Kojima T.

Mod Rheumatol. 2015 Apr 30:1-6. [Epub ahead of print]

PMID:
25775147
12.

[Management of rheumatoid arthritis medications and pregnancy].

Funakubo Asanuma Y.

Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(1):45-56. doi: 10.2177/jsci.38.45. Japanese.

13.

Interleukin-6 in rheumatoid arthritis - from the laboratory to the bedside.

Liu X, Teichtahl AJ, Wicks IP.

Curr Pharm Des. 2015;21(17):2187-97.

PMID:
25760299
14.

The effectiveness of risk communication regarding drug safety information: a nationwide survey by the Japanese public health insurance claims data.

Hagiwara H, Nakano S, Ogawa Y, Tohkin M.

J Clin Pharm Ther. 2015 Jun;40(3):273-8. doi: 10.1111/jcpt.12256. Epub 2015 Mar 6.

PMID:
25753581
15.

Evaluation of the pharmacokinetic equivalence and 54-week efficacy and safety of CT-P13 and innovator infliximab in Japanese patients with rheumatoid arthritis.

Takeuchi T, Yamanaka H, Tanaka Y, Sakurai T, Saito K, Ohtsubo H, Lee SJ, Nambu Y.

Mod Rheumatol. 2015 Apr 2:1-8. [Epub ahead of print]

PMID:
25736355
16.

Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study.

Genovese MC, Fleischmann R, Kivitz AJ, Rell-Bakalarska M, Martincova R, Fiore S, Rohane P, van Hoogstraten H, Garg A, Fan C, van Adelsberg J, Weinstein SP, Graham NM, Stahl N, Yancopoulos GD, Huizinga TW, van der Heijde D.

Arthritis Rheumatol. 2015 Jun;67(6):1424-1437. doi: 10.1002/art.39093.

PMID:
25733246
17.

Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety.

Xu Z, Davis HM, Zhou H.

J Clin Pharmacol. 2015 Mar;55 Suppl 3:S60-74. doi: 10.1002/jcph.380.

PMID:
25707965
18.

Efficacy and Safety of Anti-Interleukin-20 Monoclonal Antibody in Patients With Rheumatoid Arthritis: A Randomized Phase IIa Trial.

Šenolt L, Leszczynski P, Dokoupilová E, Göthberg M, Valencia X, Hansen BB, Cañete JD.

Arthritis Rheumatol. 2015 Jun;67(6):1438-1448. doi: 10.1002/art.39083.

PMID:
25707477
19.

Long-term safety and efficacy of treatment with subcutaneous abatacept in Japanese patients with rheumatoid arthritis who are methotrexate inadequate responders.

Amano K, Matsubara T, Tanaka T, Inoue H, Iwahashi M, Kanamono T, Nakano T, Uchimura S, Izumihara T, Yamazaki A, Karyekar CS, Takeuchi T; Japan Abatacept Study Group.

Mod Rheumatol. 2015 Mar 12:1-7. [Epub ahead of print]

PMID:
25698370
20.

Golimumab in patients with active rheumatoid arthritis after treatment with tumor necrosis factor α inhibitors: findings with up to five years of treatment in the multicenter, randomized, double-blind, placebo-controlled, phase 3 GO-AFTER study.

Smolen JS, Kay J, Doyle M, Landewé R, Matteson EL, Gaylis N, Wollenhaupt J, Murphy FT, Xu S, Zhou Y, Hsia EC.

Arthritis Res Ther. 2015 Jan 22;17(1):14. doi: 10.1186/s13075-015-0516-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk